Prostate Cancer - Radiation Oncology Clinical Trials Resources

Listed below are the Prostate Cancer - Radiation Oncology Clinical Trials offered at Cancer Treatment Center at the Kaiser Permanente Santa Clara Medical Center.

 

Title: STUDY OF SHORT TERM ANDROGEN DEPRIVATION WITH PELVIC LYMPH NODE OR PROSTATE BED ONLY RADIOTHERAPY (SPORT) IN PROSTATE CANCER PATIENTS WITH RISING PSA AFTER RADICAL PROSTATECTOMY
Phase: III
Modality: Radiation Therapy
Sponsors and Collaborators: Radiation Therapy Oncology Group (RTOG)
Protocol Number: RTOG0534
Web link: LINK TO THE WEB SITE
   
   
Title: A PHASE III STUDY COMPARING COMBINED EXTERNAL BEAM RADIATION AND TRANSPERINEAL INTERSTITIAL PERMANENT BRACHYTHERAPY WITH BRACHYTHERAPY ALONE FOR SELECTED PATIENTS WITH INTERMEDIATE RISK PROSTATIC CARCINOMA
Phase: III
Protocol Number: RTOG0232
Patient brochure : RTOG0232
Web link: LINK TO THE WEB SITE
   
   
Title:

A PHASE III PROSPECTIVE RANDOMIZED TRIAL OF DOSE-ESCALATED RADIOTHERAPY WITH OR WITHOUT SHORT-TERM ANDROGEN DEPRIVATION THERAPY FOR PATIENTS WITH INTERMEDIATE-RISK PROSTATE CANCER

Phase: III
Protocol Number: RTOG0815
Web link: LINK TO THE WEB SITE
   
   
Title: Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Phase: III
Modality: Radiation Therapy
Sponsors and Collaborators: Radiation Therapy Oncology Group (RTOG)
Protocol Number: RTOG 0924
Web link: LINK TO THE WEB SITE
   
   
Title: A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Phase: II
Modality: Radiation Therapy
Sponsors and Collaborators: Radiation Therapy Oncology Group (RTOG)
Protocol Number: RTOG0938
Web link: LINK TO THE WEB SITE

 

ONGOING STUDIES BUT CLOSED TO NEW PARTICIPANTS

   
Title: Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy
Phase: III
Modality: Radiation Therapy
Sponsors and Collaborators: Radiation Therapy Oncology Group (RTOG)
Protocol Number: RTOG 0831
Web link: LINK TO THE WEB SITE

Title: A Phase III Study of Active Surveillance Therapy Against Radical Treatment in Patients Diagnosed With Favourable Risk Prostate Cancer [START]
Phase: III
Modality: Radiation Therapy, Surgery
Sponsors and Collaborators:

NCIC Clinical Trials Group (NCI Canada)
National Cancer Institute (NCI USA)
Cancer and Leukemia Group B
Eastern Cooperative Oncology Group
Southwest Oncology Group

Protocol Number: START (Surveillance Therapy Against Radical Treatment) NCI CDR0000557348
Web link: LINK TO THE WEB SITE

 

TOP

Santa Clara

Comprehensive Cancer Care